Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Randomized Trial Of Glucose Monitoring In Glioblastoma

NCT07091864 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT07091864
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07091864 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Randomized Trial Of Glucose Monitoring In Glioblastoma
Lead sponsor
Mayo Clinic
Phase
Not applicable
Overall status
Recruiting
Start date
July 29, 2025
Completion date
November 30, 2027
Enrollment
116 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma, idh-wildtype, who grade 4 glioma